93 related articles for article (PubMed ID: 11937102)
1. Reversal of tolerance to nitroglycerin with N-acetylcysteine or captopril: a role of calcitonin gene-related peptide.
Zhou ZH; Jiang JL; Peng J; Deng HW; Li YJ
Eur J Pharmacol; 2002 Mar; 439(1-3):129-34. PubMed ID: 11937102
[TBL] [Abstract][Full Text] [Related]
2. Decrease in endogenous CGRP release in nitroglycerin tolerance: role of ALDH-2.
Chen YR; Nie SD; Shan W; Jiang DJ; Shi RZ; Zhou Z; Guo R; Zhang Z; Li YJ
Eur J Pharmacol; 2007 Sep; 571(1):44-50. PubMed ID: 17585900
[TBL] [Abstract][Full Text] [Related]
3. Involvement of calcitonin gene-related peptide in the development of tolerance to nitroglycerin in the rat.
Zhou ZH; Deng HW; Li YJ
Eur J Pharmacol; 2001 Sep; 427(2):137-41. PubMed ID: 11557266
[TBL] [Abstract][Full Text] [Related]
4. Reversal of tolerance to nitroglycerin with vinpocetine: a role of calcitonin gene-related peptide.
Nie SD; Hu CP; Chen YR; Wang S; Deng HW; Li YJ
Int J Cardiol; 2008 Apr; 125(3):436-8. PubMed ID: 17804099
[TBL] [Abstract][Full Text] [Related]
5. The depressor effect of nitroglycerin is mediated by calcitonin gene-related peptide.
Zhou ZH; Deng HW; Li YJ
Life Sci; 2001 Aug; 69(11):1313-20. PubMed ID: 11521755
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of development of tolerance to nitroglycerin by preventive administration of N-acetylcysteine in rats.
Tsuneyoshi H; Akatsuka N; Ohno M; Hara K; Ochiai M; Moroi M
Jpn Heart J; 1989 Sep; 30(5):733-41. PubMed ID: 2515322
[TBL] [Abstract][Full Text] [Related]
7. Nitroglycerin-induced release of calcitonin gene-related peptide from sensory nerves attenuates the development of nitrate tolerance.
Ghatta S; O'Rourke ST
J Cardiovasc Pharmacol; 2006 Feb; 47(2):175-81. PubMed ID: 16495753
[TBL] [Abstract][Full Text] [Related]
8. Captopril-induced reversal of nitroglycerin tolerance: role of sulfhydryl group vs. ACE-inhibitory activity.
Lawson DL; Nichols WW; Mehta P; Mehta JL
J Cardiovasc Pharmacol; 1991 Mar; 17(3):411-8. PubMed ID: 1711602
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of nitroglycerin-induced preconditioning mediated by calcitonin gene-related peptide in rat small intestine.
Dun Y; Hao YB; Wu YX; Zhang Y; Zhao RR
Eur J Pharmacol; 2001 Nov; 430(2-3):317-24. PubMed ID: 11711050
[TBL] [Abstract][Full Text] [Related]
10. Effect of captopril on acetylcholine-induced relaxation in the presence of nitroglycerin tolerance in isolated rabbit aorta.
Moroi M; Akatsuka N; Fukazawa M; Ishikawa M; Aikawa J; Namiki A; Yamaguchi T
J Vasc Res; 1995; 32(5):347-52. PubMed ID: 7578803
[TBL] [Abstract][Full Text] [Related]
11. Delayed cardioprotection induced by nitroglycerin is mediated by alpha-calcitonin gene-related peptide.
Zhou ZH; Peng J; Ye F; Li NS; Deng HW; Li YJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):253-9. PubMed ID: 11919648
[TBL] [Abstract][Full Text] [Related]
12. Improvement of preservation with cardioplegic solution by nitroglycerin-induced delayed preconditioning is mediated by calcitonin gene-related peptide.
Zhou ZH; Deng HW; Li YJ
Int J Cardiol; 2001 Dec; 81(2-3):211-8. PubMed ID: 11744139
[TBL] [Abstract][Full Text] [Related]
13. The cardioprotective effects of nitroglycerin-induced preconditioning are mediated by calcitonin gene-related peptide.
Hu CP; Li YJ; Deng HW
Eur J Pharmacol; 1999 Mar; 369(2):189-94. PubMed ID: 10206178
[TBL] [Abstract][Full Text] [Related]
14. Release of nitric oxide from glyceryl trinitrate by captopril but not enalaprilat: in vitro and in vivo studies.
Salvemini D; Pistelli A; Mollace V
Br J Pharmacol; 1993 Jun; 109(2):430-6. PubMed ID: 8358544
[TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin converting enzyme inhibitors on tolerance of nitroglycerin.
Fang Z; Li Y; Liu D; Li Y; Hao F; Liu Z
Chin Med J (Engl); 1995 Dec; 108(12):919-22. PubMed ID: 8728945
[TBL] [Abstract][Full Text] [Related]
16. The depressor and vasodilator effects of rutaecarpine are mediated by calcitonin gene-related peptide.
Hu CP; Xiao L; Deng HW; Li YJ
Planta Med; 2003 Feb; 69(2):125-9. PubMed ID: 12624816
[TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine does not modify nitroglycerin-induced tolerance in canine vascular rings.
Abdollah A; Moffat JA; Armstrong PW
J Cardiovasc Pharmacol; 1987 Apr; 9(4):445-50. PubMed ID: 2438507
[TBL] [Abstract][Full Text] [Related]
18. Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
Buikema H; Monnink SH; Tio RA; Crijns HJ; de Zeeuw D; van Gilst WH
Br J Pharmacol; 2000 Aug; 130(8):1999-2007. PubMed ID: 10952693
[TBL] [Abstract][Full Text] [Related]
19. Formation of releasable NO stores by S-nitrosoglutathione in arteries exhibiting tolerance to glyceryl-trinitrate.
Sarr M; Lobysheva I; Diallo AS; Stoclet JC; Schini-Kerth VB; Muller B
Eur J Pharmacol; 2005 Apr; 513(1-2):119-23. PubMed ID: 15878716
[TBL] [Abstract][Full Text] [Related]
20. Delayed cardioprotection afforded by nitroglycerin is mediated by alpha-CGRP via activation of inducible nitric oxide synthase.
Du YH; Peng J; Huang ZZ; Jiang DJ; Deng HW; Li YJ
Int J Cardiol; 2004 Jan; 93(1):49-54. PubMed ID: 14729435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
